These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 1748799)

  • 1. Effect of simultaneous isoniazid administration on pharmacokinetic parameters of pyrazinamide.
    Singhal KC; Varshney MK
    J Indian Med Assoc; 1991 Aug; 89(8):227-9. PubMed ID: 1748799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of isoniazid in pulmonary tuberculosis--a comparative study at two dose levels.
    Roy V; Tekur U; Chopra K
    Indian Pediatr; 1996 Apr; 33(4):287-91. PubMed ID: 8772902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum concentrations of rifampicin and isoniazid in tuberculosis.
    Seth V; Beotra A; Seth SD; Semwal OP; Kabra S; Jain Y; Mukhopadhya S
    Indian Pediatr; 1993 Sep; 30(9):1091-8. PubMed ID: 8125594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum concentration and urinary excretion of ethambutol administered alone and in combination with isoniazid in patients of pulmonary tuberculosis.
    Singhal KC; Rathi R; Varshney DP; Kishore K
    Indian J Physiol Pharmacol; 1985; 29(4):223-6. PubMed ID: 3842376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of pyrazinamide in children suffering from pulmonary tuberculosis.
    Roy V; Tekur U; Chopra K
    Int J Tuberc Lung Dis; 1999 Feb; 3(2):133-7. PubMed ID: 10091878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of pyrazinamide on rifampicin kinetics in patients with tuberculosis.
    Jain A; Mehta VL; Kulshrestha S
    Tuber Lung Dis; 1993 Apr; 74(2):87-90. PubMed ID: 8324212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of antituberculosis drugs after oral isolated and simultaneous administration in triple combination.
    Zítková L; Janků I; Tousek J; Papezová E; Stastná J
    Czech Med; 1983; 6(4):202-17. PubMed ID: 6420125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clearance of theophylline is increased during the initial period of tuberculosis treatment.
    Ahn HC; Lee YC
    Int J Tuberc Lung Dis; 2003 Jun; 7(6):587-91. PubMed ID: 12797703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative bioavailability of rifampicin, isoniazid and pyrazinamide from a four drug fixed dose combination with separate formulations at the same dose levels.
    Agrawal S; Singh I; Kaur KJ; Bhade SR; Kaul CL; Panchagnula R
    Int J Pharm; 2004 May; 276(1-2):41-9. PubMed ID: 15113612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyrazinamide serum levels in childhood tuberculosis.
    Thee S; Detjen A; Wahn U; Magdorf K
    Int J Tuberc Lung Dis; 2008 Sep; 12(9):1099-101. PubMed ID: 18713511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacokinetic aspects of tuberculosis therapy with a fixed combination of rifampicin, isoniazide and pyrazinamide].
    Schaberg T; Lode H
    Z Gesamte Inn Med; 1991 Jun; 46(8):276-9. PubMed ID: 1897286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacokinetic factors and bioavailability of rifampicin, isoniazid and pyrazinamid fixed in one dose capsule.
    Zwolska Z; Augustynowicz-Kopeć E; Niemirowska-Mikulska H
    Acta Pol Pharm; 2002; 59(6):448-52. PubMed ID: 12669769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does AIDS impair the absorption of antituberculosis agents?
    Taylor B; Smith PJ
    Int J Tuberc Lung Dis; 1998 Aug; 2(8):670-5. PubMed ID: 9712282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tisamide in the complex treatment of tuberculosis].
    Onishchenko VV; Sokolova GB; Koriakin VA; Shapatava MN; Iurchenko LN
    Probl Tuberk; 1990; (7):43-5. PubMed ID: 2235951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Six-month short course chemotherapy containing pyrazinamide for initial treatment of pulmonary tuberculosis].
    Wada M; Yosiyama T; Yosikawa M; Ogata H; Sugie T; Nakasono T; Sugita H
    Kekkaku; 1994 Nov; 69(11):671-80. PubMed ID: 7837720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pharmacokinetics of pioglitazone in Thai healthy subjects.
    Wittayalertpanya S; Chompootaweep S; Thaworn N
    J Med Assoc Thai; 2006 Dec; 89(12):2116-22. PubMed ID: 17214065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of pyrazinamide in children with primary progressive disease of lungs.
    Arya DS; Ojha SK; Semwal OP; Nandave M
    Indian J Med Res; 2008 Nov; 128(5):611-5. PubMed ID: 19179681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The disposition of antituberculous drugs in plasma of elderly patients. II. Isoniazid, rifampicin and pyrazinamide.
    Walubo A; Chan K; Woo J; Chan HS; Wong CL
    Methods Find Exp Clin Pharmacol; 1991 Oct; 13(8):551-6. PubMed ID: 1956210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of pyrazinamide and rifampicin on isoniazid metabolism in rats.
    De Rosa HJ; Baldan HM; Brunetti IL; Ximenes VF; Machado RG
    Biopharm Drug Dispos; 2007 Sep; 28(6):291-6. PubMed ID: 17571294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [In 76% of patients with active tuberculosis treated with triple therapy (isoniazid-rifampicin-pyrazinamide) cultural conversion precedes microscopic conversion].
    Nowak D; Radenbach D; Magnussen H
    Pneumologie; 1990 Feb; 44 Suppl 1():497-8. PubMed ID: 2114634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.